InvestorsHub Logo
Followers 78
Posts 24618
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 03/11/2024 8:00:01 AM

Monday, March 11, 2024 8:00:01 AM

Post# of 27534
LXRX - 2.17 Pre-market at 2.36/2.38

Lexicon shares are trading higher after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.